Skip to main content

J&J Cleared Over Asbestos Cancer Claims Linked To Talcum

J&J Cleared Over Asbestos Cancer Claims Linked To Talcum

J&J Cleared Over Asbestos Cancer Claims Linked To Talcum

Introduction

Following almost a seven-week long jury trial, Johnson & Johnson was successful in persuading a California jury to dismiss claims made by a woman that the asbestos presence in its talcum baby powder caused her to develop malignant mesothelioma.  

The plaintiff alleged that J&J knew of asbestos fibers in its talc-based products and concealed the risks associated with them. Though the Eureka State Jury agreed the plaintiff was exposed to asbestos-tainted baby powder but reasoned wasn’t a “substantial factor” in causing her cancer.

J&J released a statement in response to its latest win stating, "While we deeply sympathize with anyone suffering from any form of cancer, the science and facts show that her disease was not caused by her use of our talcum-based products". A company spokesperson further said, ''decades of clinical evidence and scientific studies by medical experts around the world support the safety of Johnson’s Baby Powder.”

J&J is also one of the main defendants involved in fighting more than 9,700 talc ovarian cancer lawsuits for several years.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Teen E-cigarette Use Hits 10-Year Low

Categories: E-Cigarette: JUUL

Federal officials report a significant decline in teen vaping rates in the U.S., with about half a million fewer middle and high school…

Baltimore, Walgreens Reach Opioid Settlement Totaling $402.5m

Categories: Opioids

The City of Baltimore has reached a settlement with Walgreens over its involvement in the opioid crisis, marking the…

Drug Distributors Reach $300M Opioid Settlement

Categories: Opioids

The three largest U.S. drug distributors—McKesson Corp, Cencora Inc, and Cardinal Health Inc—have agreed to pay $300 million to settle claims by health insurers and benefit plans over their role in fueling the U.S.…

Labor Day Litigation Bonanza!     
Free Trials + 15% Discount!